Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06119425Not ApplicableCompleted

Blood-Based Colorectal Cancer (CRC) Screening Implementation Into Clinical Practice Highlands

Role: lead

NCT06120985Not ApplicableCompleted

Rural Appalachia Pilot Water Treatment Trial

Role: collaborator

NCT06849518Not ApplicableRecruiting

Study of Longitudinal Plasma PD-L1 Testing With Immunotherapy in Lung Cancer

Role: lead

NCT06424119Not ApplicableRecruiting

Multi-Center Study of Clinical and Inflammatory Outcomes in Intensive Cardiac Rehabilitation and Traditional Cardiac Rehabilitation Programs

Role: collaborator

All 4 trials loaded